Literature DB >> 18238848

Low-grade glioma: correlation of short echo time 1H-MR spectroscopy with 23Na MR imaging.

R Bartha1, J F Megyesi, C J Watling.   

Abstract

BACKGROUND AND
PURPOSE: There is considerable variability in the clinical behavior and treatment response of low-grade (WHO grade II) gliomas. The purpose of this work was to characterize the metabolic profile of low-grade gliomas by using short echo time (1)H-MR spectroscopy and to correlate metabolite levels with MR imaging-measured sodium ((23)Na) signal intensity. Based on previous studies, we hypothesized decreased N-acetylaspartate (NAA) and increased myo-inositol (mIns), choline (Cho), glutamate (Glu), and (23)Na signal intensity in glioma tissue.
MATERIALS AND METHODS: Institutional ethics committee approval and informed consent were obtained for all of the subjects. Proton ((1)H-MR) spectroscopy (TR/TE = 2200/46 ms) and sodium ((23)Na) MR imaging were performed at 4T in 13 subjects (6 women and 7 men; mean age, 44 years) with suspected low-grade glioma. Absolute metabolite levels were quantified, and relative (23)Na levels were measured in low-grade glioma and compared with the contralateral side in the same patients. Two-sided Student t tests were used to test for statistical significance.
RESULTS: Significant decreases were observed for NAA (P < .001) and Glu (P = .004), and increases were observed for mIns (P = .003), Cho (P = .025), and sodium signal intensity (P < .001) in low-grade glioma tissue. Significant correlations (r(2) > 0.25) were observed between NAA and Glu (P < .05) and between NAA and mIns (P < .01). Significant correlations were also observed between (23)Na signal intensity and NAA (P < .01) and between (23)Na signal intensity and Glu (P < .01). Ratios of NAA/mIns, NAA/(23)Na, and NAA/Cho were altered in glioma tissue (P < .001); however based on the t statistic, NAA/(23)Na (t = 9.6) was the most significant, followed by NAA/mIns (t = 6.1), and NAA/Cho (t = 5.0).
CONCLUSION: Although Glu concentration is reduced and mIns concentration is elevated in low-grade glioma tissue, the NAA/(23)Na ratio was the most sensitive indicator of pathologic tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18238848      PMCID: PMC8118860          DOI: 10.3174/ajnr.A0854

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  40 in total

1.  Spectroscopic lineshape correction by QUECC: combined QUALITY deconvolution and eddy current correction.

Authors:  R Bartha; D J Drost; R S Menon; P C Williamson
Journal:  Magn Reson Med       Date:  2000-10       Impact factor: 4.668

2.  Theoretical basis for sodium and potassium MRI of the human heart at 1.5 T.

Authors:  T B Parrish; D S Fieno; S W Fitzgerald; R M Judd
Journal:  Magn Reson Med       Date:  1997-10       Impact factor: 4.668

3.  Effect of signal-to-noise ratio and spectral linewidth on metabolite quantification at 4 T.

Authors:  Robert Bartha
Journal:  NMR Biomed       Date:  2007-08       Impact factor: 4.044

4.  Fast three dimensional sodium imaging.

Authors:  F E Boada; J S Gillen; G X Shen; S Y Chang; K R Thulborn
Journal:  Magn Reson Med       Date:  1997-05       Impact factor: 4.668

5.  Experimental and human brain neoplasms: detection with in vivo sodium MR imaging.

Authors:  P A Turski; L W Houston; W H Perman; J K Hald; D Turski; C M Strother; J F Sackett
Journal:  Radiology       Date:  1987-04       Impact factor: 11.105

6.  Sodium-23 magnetic resonance brain imaging.

Authors:  S S Winkler
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

7.  Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging.

Authors:  Ronald Ouwerkerk; Karen B Bleich; Joseph S Gillen; Martin G Pomper; Paul A Bottomley
Journal:  Radiology       Date:  2003-03-27       Impact factor: 11.105

8.  Correlation of myo-inositol levels and grading of cerebral astrocytomas.

Authors:  M Castillo; J K Smith; L Kwock
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

9.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.

Authors:  F A Howe; S J Barton; S A Cudlip; M Stubbs; D E Saunders; M Murphy; P Wilkins; K S Opstad; V L Doyle; M A McLean; B A Bell; J R Griffiths
Journal:  Magn Reson Med       Date:  2003-02       Impact factor: 4.668

Review 10.  In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI.

Authors:  Sarah J Nelson; Edward Graves; Andrea Pirzkall; Xiaojuan Li; Antionette Antiniw Chan; Daniel B Vigneron; Tracy R McKnight
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

View more
  10 in total

Review 1.  Quantitative sodium MR imaging: A review of its evolving role in medicine.

Authors:  Keith R Thulborn
Journal:  Neuroimage       Date:  2016-11-24       Impact factor: 6.556

Review 2.  Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.

Authors:  Andre D Furtado; Rafael Ceschin; Stefan Blüml; Gary Mason; Regina I Jakacki; Hideho Okada; Ian F Pollack; Ashok Panigrahy
Journal:  Neuroimaging Clin N Am       Date:  2017-02       Impact factor: 2.264

3.  Sodium MRI at 7T for Early Response Evaluation of Intracranial Tumors following Stereotactic Radiotherapy Using the CyberKnife.

Authors:  L Huang; J Bai; R Zong; J Zhou; Z Zuo; X Chai; Z Wang; J An; Y Zhuo; F Boada; X Yu; Z Ling; B Qu; L Pan; Z Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2022-02       Impact factor: 3.825

4.  Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment.

Authors:  Elavarasan Subramani; Marina Radoul; Chloe Najac; Georgios Batsios; Abigail R Molloy; Donghyun Hong; Anne Marie Gillespie; Romelyn Delos Santos; Pavithra Viswanath; Joseph F Costello; Russell O Pieper; Sabrina M Ronen
Journal:  Cancer Res       Date:  2020-09-21       Impact factor: 12.701

5.  Quantitative sodium imaging and gliomas: a feasibility study.

Authors:  Lucidio P Nunes Neto; Guillaume Madelin; Terlika Pandit Sood; Chih-Chun Wu; Douglas Kondziolka; Dimitris Placantonakis; John G Golfinos; Andrew Chi; Rajan Jain
Journal:  Neuroradiology       Date:  2018-06-03       Impact factor: 2.804

Review 6.  Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches.

Authors:  Risto A Kauppinen; Andrew C Peet
Journal:  Cancer Biol Ther       Date:  2011-10-15       Impact factor: 4.742

Review 7.  Sodium homeostasis in the tumour microenvironment.

Authors:  Theresa K Leslie; Andrew D James; Fulvio Zaccagna; James T Grist; Surrin Deen; Aneurin Kennerley; Frank Riemer; Joshua D Kaggie; Ferdia A Gallagher; Fiona J Gilbert; William J Brackenbury
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-07-23       Impact factor: 10.680

8.  Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

Authors:  Lina Mörén; Richard Perryman; Tim Crook; Julia K Langer; Kevin Oneill; Nelofer Syed; Henrik Antti
Journal:  BMC Cancer       Date:  2018-02-08       Impact factor: 4.430

9.  Terahertz reflectometry imaging for low and high grade gliomas.

Authors:  Young Bin Ji; Seung Jae Oh; Seok-Gu Kang; Jung Heo; Sang-Hoon Kim; Yuna Choi; Seungri Song; Hye Young Son; Se Hoon Kim; Ji Hyun Lee; Seung Joo Haam; Yong Min Huh; Jong Hee Chang; Chulmin Joo; Jin-Suck Suh
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

Review 10.  Use of MRI, metabolomic, and genomic biomarkers to identify mechanisms of chemoresistance in glioma.

Authors:  Cathy W Levenson; Thomas J Morgan; Pamela D Twigg; Timothy M Logan; Victor D Schepkin
Journal:  Cancer Drug Resist       Date:  2019-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.